JAK inhibitori u bolesnika s visokim ka rdiovaskularnim rizikom – pro et contra JAK inhibitors in patients with high cardiovascular risk – pro et contraAuthors:Mislav Radić Summary Sažetak Vol.: 2025;72(Supl 1/Suppl 1) https://doi.org/10.33004/reumatizam-supp-72-1-25 Mislav Radić Preuzmi PDF Draženka Kontek2025-11-28T13:47:09+01:00 Podijeli članak FacebookXLinkedInWhatsAppEmail:
